Evaluation of the Relationship Between Pharmacokinetics and the Safety of Aripiprazole and Its Cardiovascular Effects in Healthy Volunteers
Open Access
- 1 December 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 36 (6) , 608-614
Abstract
Aims: The aim of this study was the evaluation of the possible relationship between pharmacokinetics and the safety of aripiprazole as well as its influence on blood pressure (BP), heart rate (HR), and corrected QT (QTc) interval. Methods: The study population comprised 157 healthy volunteers from 6 bioequivalence clinical trials. Subjects were administered a single 10-mg oral dose of each formulation separated by a 28-day washout period. Plasma concentrations were measured using high-performance liquid chromatography coupled to mass spectrometry. Blood pressure was measured at the following times: predose and 0.5, 2, 4, 6, and 8 hours postdose. An electrocardiogram was recorded at predose, 4, and 8 hours postdose. Results: Area under the curve (AUC), maximum plasma concentration, half-life, and distribution volume corrected for weight were higher in women. Aripiprazole treatment produced a decrease of BP (9.3 mm Hg on systolic and 6.2 mm Hg on diastolic pressure) and an increase in HR (12.1 beats per minute) and QTc interval (9.1 milliseconds). There were sex differences in BP, HR, and QTc interval. Women and subjects with higher AUC and maximum plasma concentration values were more prone to experience adverse drug reactions and gastrointestinal adverse reactions. The AUC was related with systolic BP and diastolic BP decrease and HR increase but there was no relationship between aripiprazole concentrations and QTc increase. Conclusions: Aripiprazole decreases BP and increases HR and QTc interval. Pharmacokinetics, pharmacodynamics, and safety of aripiprazole are affected by sex. There is a directly proportional relationship between pharmacokinetic parameters and adverse drug reactions and effect on BP and HR.Keywords
This publication has 49 references indexed in Scilit:
- Sex and gender differences in control of blood pressureClinical Science, 2013
- Worsened hypertension control induced by aripiprazoleNeuropsychiatric Disease and Treatment, 2013
- AripiprazoleDrugs, 2012
- Cardiovascular safety of aripiprazole and pimozide in young patients with Tourette syndromeNeurological Sciences, 2011
- Drug‐ and non‐drug‐associated QT interval prolongationBritish Journal of Clinical Pharmacology, 2010
- Second-Generation AntipsychoticsDrug Safety, 2006
- Drug-Induced Prolongation of the QT IntervalNew England Journal of Medicine, 2004
- AripiprazoleDrugs, 2004
- The Influence of Sex on PharmacokineticsClinical Pharmacokinetics, 2003
- Physiological Changes During the Menstrual Cycle and Their Effects on the Pharmacokinetics and Pharmacodynamics of DrugsClinical Pharmacokinetics, 1998